Objective: To report the clinical outcome of urethral reconstruction by cultured ur- othelial or oral mucosa cells for tissue-engineered urethroplasty.
MukoCell, a tissue-engineered mucosa, is about to confirm the therapeutic efficacy in the plastic reconstruction of urethra in a prospective randomised clinical trial.
Events and congresses contributions on the subject of urethral reconstruction (urethroplasty) with MukoCell®
DetailsAuthors: Prof. Guido Barbagli, Dr. med. Gouya Ram-Liebig Native oral mucosa is implanted since many years as graft for urethroplasty. However, its excision from the mouth may be associated with potential complications and morbidities at oral site. Early complications include pain, numbness, bleeding, and infection while longer-term complications comprise oral tightness and restriction of…
DetailsThe ready availability of tissues and organs to replace and repair those that have been damaged is an important clinical need. The field of tissue engineering might offer an innovative solution.
DetailsIn Europe TEPs, somatic cell therapy medicinal products, and gene therapy medicinal products are summarised under the term advanced therapy medicinal products (ATMP) [1,2]. TEPs contain viable autolo- gous, allogenic or xenogenic cells.
DetailsThe following publication shows the development of the first urology tissue engineering product starting from preclinic to market approval in Germany:
Details